POINT
发表于 2025-3-23 12:18:15
http://reply.papertrans.cn/88/8773/877255/877255_11.png
Robust
发表于 2025-3-23 15:28:19
http://reply.papertrans.cn/88/8773/877255/877255_12.png
Cosmopolitan
发表于 2025-3-23 20:14:43
http://reply.papertrans.cn/88/8773/877255/877255_13.png
aggrieve
发表于 2025-3-24 01:50:09
http://reply.papertrans.cn/88/8773/877255/877255_14.png
blight
发表于 2025-3-24 04:35:28
iltrating cholangiocarcinoma, and false-positive inflammatory lesions. It is not helpful to identify HCC in patients with cirrhosis and regenerating nodules. In patients with primary malignant hepatic tumors that accumulate FDG, PET imaging does identify unexpected distant metastases (although milia
不可知论
发表于 2025-3-24 06:57:19
http://reply.papertrans.cn/88/8773/877255/877255_16.png
Acquired
发表于 2025-3-24 14:12:22
Christel Herold-Mende,Benito Campositten by international leaders in PET and PET/CT.Includes suThe use of positron emission tomography (PET) in clinical practice is key to the s- cessful management of many patients with a wide variety of diseases. Whereas in the 1980s and 1990s nuclear medicine physicians struggled to convince other
jumble
发表于 2025-3-24 16:22:28
http://reply.papertrans.cn/88/8773/877255/877255_18.png
pantomime
发表于 2025-3-24 19:19:47
Charlotte Aaberg-Jessen,Karina Christensen,Bjarne Winther Kristensennt of using of short-lived β.-emitting tracers, especially .C in medicine. There is no doubt that from the synthetic perspective the potential of .C as a radionuclide in future tracer development, even for clinical applications, is outstanding. However, there are still severe problems which need to
抛弃的货物
发表于 2025-3-25 03:02:53
http://reply.papertrans.cn/88/8773/877255/877255_20.png